288,798 Shares in Johnson Controls International plc (NYSE:JCI) Purchased by Public Employees Retirement System of Ohio

Public Employees Retirement System of Ohio acquired a new position in shares of Johnson Controls International plc (NYSE:JCI - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm acquired 288,798 shares of the company's stock, valued at approximately $22,795,000.

Several other institutional investors also recently bought and sold shares of JCI. Compass Financial Services Inc purchased a new position in shares of Johnson Controls International in the 4th quarter valued at $26,000. SBI Securities Co. Ltd. purchased a new position in shares of Johnson Controls International in the 4th quarter valued at $29,000. Synergy Asset Management LLC purchased a new position in shares of Johnson Controls International in the 4th quarter valued at $42,000. Crowley Wealth Management Inc. purchased a new position in shares of Johnson Controls International in the 4th quarter valued at $42,000. Finally, Gables Capital Management Inc. increased its holdings in shares of Johnson Controls International by 132.0% in the 4th quarter. Gables Capital Management Inc. now owns 580 shares of the company's stock valued at $46,000 after acquiring an additional 330 shares during the period. 90.05% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research analysts recently weighed in on JCI shares. JPMorgan Chase & Co. boosted their target price on Johnson Controls International from $81.00 to $98.00 and gave the stock an "overweight" rating in a research note on Friday, May 16th. Deutsche Bank Aktiengesellschaft raised Johnson Controls International from a "hold" rating to a "buy" rating and lifted their price target for the stock from $101.00 to $112.00 in a research report on Monday, May 12th. Barclays lifted their price target on Johnson Controls International from $85.00 to $90.00 and gave the stock an "equal weight" rating in a research report on Wednesday, May 14th. Citigroup lowered their price target on Johnson Controls International from $95.00 to $85.00 and set a "neutral" rating for the company in a research report on Monday, April 14th. Finally, Vertical Research raised Johnson Controls International from a "hold" rating to a "buy" rating and set a $105.00 price target for the company in a research report on Thursday, May 8th. Eight equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $96.12.

Insiders Place Their Bets

In other Johnson Controls International news, Director George Oliver sold 15,669 shares of the firm's stock in a transaction dated Friday, March 14th. The stock was sold at an average price of $77.49, for a total transaction of $1,214,190.81. Following the transaction, the director now owns 1,003,893 shares of the company's stock, valued at approximately $77,791,668.57. This trade represents a 1.54% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Marc Vandiepenbeeck sold 28,289 shares of the firm's stock in a transaction dated Thursday, May 8th. The stock was sold at an average price of $90.92, for a total value of $2,572,035.88. Following the transaction, the chief financial officer now directly owns 147,673 shares in the company, valued at approximately $13,426,429.16. The trade was a 16.08% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 331,133 shares of company stock valued at $27,845,646. 0.54% of the stock is currently owned by insiders.

Johnson Controls International Stock Up 0.3%

Shares of NYSE JCI traded up $0.30 during mid-day trading on Wednesday, hitting $101.32. The company had a trading volume of 5,432,540 shares, compared to its average volume of 4,285,544. The company has a market capitalization of $66.67 billion, a PE ratio of 38.67, a price-to-earnings-growth ratio of 1.96 and a beta of 1.28. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.02 and a quick ratio of 0.86. Johnson Controls International plc has a 1-year low of $64.31 and a 1-year high of $102.92. The business's 50-day simple moving average is $84.76 and its 200 day simple moving average is $83.25.

Johnson Controls International (NYSE:JCI - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.82 earnings per share for the quarter, beating analysts' consensus estimates of $0.77 by $0.05. Johnson Controls International had a return on equity of 15.11% and a net margin of 6.83%. The company had revenue of $5.68 billion for the quarter, compared to analysts' expectations of $5.64 billion. During the same period last year, the firm earned $0.78 earnings per share. Johnson Controls International's quarterly revenue was up 1.4% on a year-over-year basis. On average, analysts predict that Johnson Controls International plc will post 3.64 earnings per share for the current year.

Johnson Controls International Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, April 17th. Shareholders of record on Monday, March 24th were paid a $0.37 dividend. This represents a $1.48 dividend on an annualized basis and a yield of 1.46%. The ex-dividend date of this dividend was Monday, March 24th. Johnson Controls International's dividend payout ratio is presently 39.47%.

Johnson Controls International Profile

Johnson Controls International plc, together with its subsidiaries, engages in engineering, manufacturing, commissioning, and retrofitting building products and systems in the United States, Europe, the Asia Pacific, and internationally. It operates in four segments: Building Solutions North America, Building Solutions EMEA/LA, Building Solutions Asia Pacific, and Global Products.